Sort by
Refine Your Search
-
of this research program—spanning basic mechanistic discoveries, application of high-throughput technologies, validation in cancer-relevant mouse models, and translation platforms—is to understand the fundamental
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01
-
Writing for scholarly and applied audiences Delivering presentations to diverse stakeholders Preferred qualifications: Extensive knowledge of and experience with instructional technology and online learning
-
) Founding member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant